A Model of Neuregulin Control of NMDA Receptors on Synaptic Spines

Bulletin of Mathematical Biology

Volumn 74, Issue 3, 2012, Pages 717-735

  Bennett, Max R ^a   Farnell, Les ^a   Gibson, William G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

ErbB; Phosphorylation; Src kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEU DIFFERENTIATION FACTOR; PROTEIN TYROSINE KINASE; RECEPTOR TYROSINE PROTEIN KINASE ERBB 4; RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; DENDRITIC SPINE; DISEASE MODEL; METABOLISM; PHOSPHORYLATION; SCHIZOPHRENIA; SYNAPSE;

ANIMALS; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; MODELS, NEUROLOGICAL; NEUREGULIN-1; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SRC-FAMILY KINASES; SYNAPSES;

ANIMALIA;

EID: 84856697340     PISSN: 00928240     EISSN: 15229602     Source Type: Journal    
DOI: 10.1007/s11538-011-9706-9     Document Type: Article

References (41)

1. Ali, D., & Salter, M. (2001). NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Curr. Opin. Neurobiol., 11(3), 336-342.
2. Bennett, M. (2009). Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression. Aust. N. Z. J. Psychiatry, 43(8), 711-721.
3. Bennett, M., Farnell, L., & Gibson, W. (2011). A model of NMDA receptor control of F-actin treadmilling in synaptic spines and their growth. Bull Math. Biol. 73, 2109-2131.
4. Bjarnadottir, M., Misner, D., Haverfield-Gross, S., Bruun, S., Helgason, V., Stefansson, H., Sigmundsson, A., Firth, D., Nielsen, B., Stefansdottir, R., et al. (2007). Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/-knock-outs compared with wild-type mice. J. Neurosci., 27(17), 4519-4529.
5. Carlsson, A. (2006). The neurochemical circuitry of schizophrenia. Pharmacopsychiatry, 39(Suppl. 1), S10-S14.
6. Carlsson, M., & Carlsson, A. (1990). Schizophrenia: A subcortical neurotransmitter imbalance syndrome? Schizophr. Bull., 16(3), 425-432.
7. Chattopadhyay, A., Vecchi, M., Ji, Q., Mernaugh, R., & Carpenter, G. (1999). The role of individual SH2 domains in mediating association of phospholipase C-gamma 1 with the activated EGF receptor. J. Biol. Chem., 274(37), 26091-26097.
8. Chong, V., Thompson, M., Beltaifa, S., Webster, M., Law, A., & Weickert, C. (2008). Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr. Res., 100(1-3), 270-280.
9. Chung, H., Huang, Y., Lau, L., & Huganir, R. (2004). Regulation of the NMDA receptor complex and trafficking by activity-dependent phosphorylation of the NR2B subunit PDZ ligand. J. Neurosci., 24(45), 10248-10259.
10. de Mol, N., Catalina, M., Fischer, M., Broutin, I., Maier, C., & Heck, A. (2004). Changes in structural dynamics of the Grb2 adaptor protein upon binding of phosphotyrosine ligand to its SH2 domain. Biochim. Biophys. Acta, Proteins Proteomics, 1700(1), 53-64.
11. Gingrich, J., Pelkey, K., Fam, S., Huang, Y., Petralia, R., Wenthold, R., & Salter, M. (2004). Unique domain anchoring of Src to synaptic NMDA receptors via the mitochondrial protein NADH dehydrogenase subunit 2. Proc. Natl. Acad. Sci., 101(16), 6237-6242.
12. Gu, Z., Jiang, Q., Fu, A., Ip, N., & Yan, Z. (2005). Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J. Neurosci., 25(20), 4974-4984.
13. Hahn, C., Wang, H., Cho, D., Talbot, K., Gur, R., Berrettini, W., Bakshi, K., Kamins, J., Borgmann-Winter, K., Siegel, S., et al. (2006). Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat. Med., 12, 824-828.
14. Hatakeyama, M., Kimura, S., Naka, T., Kawasaki, T., Yumoto, N., Ichikawa, M., Kim, J., Saito, K., Saeki, M., Shirouzu, M., et al. (2003). A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling. Biochem. J., 373(Pt 2), 451-463.
15. Holbro, T., & Hynes, N. (2004). ErbB receptors: directing key signaling networks throughout life. Annu. Rev. Pharmacol. Toxicol., 44, 195-217.
16. Huang, Y., Won, S., Ali, D., Wang, Q., Tanowitz, M., Du, Q., Pelkey, K., Yang, D., Xiong, W., Salter, M., et al. (2000). Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron, 26(2), 443-455.
17. Kalia, L., Gingrich, J., & Salter, M. (2004). Src in synaptic transmission and plasticity. Oncogene, 23(48), 8007-8016.
18. Kalia, L., Pitcher, G., Pelkey, K., & Salter, M. (2006). PSD-95 is a negative regulator of the tyrosine kinase Src in the NMDA receptor complex. EMBO J., 25(20), 4971-4982.
19. Kholodenko, B., Demin, O., Moehren, G., & Hoek, J. (1999). Quantification of short term signaling by the epidermal growth factor receptor. J. Biol. Chem., 274(42), 30169-30181.
20. Kwon, O., Longart, M., Vullhorst, D., Hoffman, D., & Buonanno, A. (2005). Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses. J. Neurosci., 25(41), 9378-9383.
21. Law, A., Kleinman, J., Weinberger, D., & Weickert, C. (2007). Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum. Mol. Genet., 16(2), 129-141.
22. Li, B., Woo, R., Mei, L., & Malinow, R. (2007). The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron, 54(4), 583-597.
23. Lu, Y., Roder, J., Davidow, J., & Salter, M. (1998). Src activation in the induction of long-term potentiation in CA1 hippocampal neurons. Science, 279(5355), 1363-1367.
24. Ma, L., Huang, Y., Pitcher, G., Valtschanoff, J., Ma, Y., Feng, L., Lu, B., Xiong, W., Salter, M., Weinberg, R., et al. (2003). Ligand-dependent recruitment of the ErbB4 signaling complex into neuronal lipid rafts. J. Neurosci., 23(8), 3164-3175.
25. Moehren, G., Markevich, N., Demin, O., Kiyatkin, A., Goryanin, I., Hoek, J., & Kholodenko, B. (2002). Temperature dependence of the epidermal growth factor receptor signaling network can be accounted for by a kinetic model. Biochemistry, 41(1), 306-320.
26. Nakakuki, T., Yumoto, N., Naka, T., Shirouzu, M., Yokoyama, S., & Hatakeyama, M. (2008). Topological analysis of MAPK cascade for kinetic ErbB signaling. PLoS ONE, 3(3).
27. Newpher, T., & Ehlers, M. (2009). Spine microdomains for postsynaptic signaling and plasticity. Trends Cell Biol., 19(5), 218-227.
28. Pereira, A., Fink, G., & Sundram, S. (2009). Clozapine-induced ERK1 and ERK2 signaling in prefrontal cortex is mediated by the EGF receptor. J. Mol. Neurosci., 39(1), 185-198.
29. Pitcher, G., Kalia, L., Ng, D., Goodfellow, N., Yee, K., Lambe, E., & Salter, M. (2011). Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors. Nat. Med., 17(4), 470-478.
30. Roysommuti, S., Carroll, S., & Wyss, J. (2003). Neuregulin-1β modulates in vivo entorhinal-hippocampal synaptic transmission in adult rats. Neuroscience, 121(3), 779-785.
31. Salter, M. (2001). LTP gets culture. Trends Neurosci., 24(10), 560-561.
32. Schoeberl, B., Eichler-Jonsson, C., Gilles, E., & Muller, G. (2002). Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat. Biotechnol., 20(4), 370-375.
33. Schulze, W., Deng, L., & Mann, M. (2005). Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol. Syst. Biol., 1(1), 2005-2008.
34. Stefansson, H., Petursson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., et al. (2002). Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet., 71(4), 877-892.
35. Wang, Y., & Salter, M. (1994). Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature, 369, 233-235.
36. Woo, R., Li, X., Tao, Y., Carpenter-Hyland, E., Huang, Y., Weber, J., Neiswender, H., Dong, X., Wu, J., Gassmann, M., et al. (2007). Neuregulin-1 enhances depolarization-induced GABA release. Neuron, 54(4), 599-610.
37. Xu, J., Weerapura, M., Ali, M., Jackson, M., Li, H., Lei, G., Xue, S., Kwan, C., Manolson, M., Yang, K., et al. (2008). Control of excitatory synaptic transmission by C-terminal SRC kinase. J. Biol. Chem., 283(25), 17503-17514.
38. Yaish, P., Gazit, A., Gilon, C., & Levitzki, A. (1988). Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science, 242(4880), 933-935.
39. Yu, X., Askalan, R., Keil, G., & Salter, M. (1997). NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science, 275(5300), 674-678.
40. Zhou, W., & Carpenter, G. (2001). Heregulin-dependent translocation and hyperphosphorylation of ErbB-2. Oncogene (Basingstoke), 20(29), 3918-3920.
41. Zhou, W., & Carpenter, G. (2002). ErbB-4: a receptor tyrosine kinase. Inflamm. Res., 51(2), 91-101.